Physician profile
Derek Ryan Miller
NPI 1538457619
$3,031.87
in general payments reported to CMS, 2019-2025
35 companies · $602 in 2025
The $602 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $591 · 2020: $294 · 2021: $132 · 2022: $552 · 2023: $346 · 2024: $515 · 2025: $602.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,463.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $709.79 | 2019-2025 | Variax, Pangea, Augment Injectable |
| Depuy Synthes Sales INC. | $287.80 | 2019-2025 | Motoband |
| Treace Medical Concepts, INC. | $200.43 | 2022-2025 | |
| Wright Medical Technology, INC. | $137.32 | 2019-2020 | |
| Smith+Nephew, INC. | $128.82 | 2022-2024 | Grafix Pl, Bone Anchors With Arthroscopic Delivery System, Q-Fix |
| Kerecis Limited | $121.87 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Integra Lifesciences Corporation | $116.65 | 2019-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Orthofix Medical, INC. | $95.19 | 2019-2025 | Physio-Stim, Accelstim |
| Nevro Corp. | $93.55 | 2022 | |
| Paratek Pharmaceuticals, INC. | $87.36 | 2020-2024 | Nuzyra |
| Djo, LLC | $83.41 | 2022-2024 | Cmf |
| Musculoskeletal Transplant Foundation INC. | $74.01 | 2022 | |
| Bioventus LLC | $72.27 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Heron Therapeutics, INC. | $72.18 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $70.95 | 2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $65.78 | 2021-2022 | |
| In2bones USA, LLC | $55.00 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $52.35 | 2024-2025 | Exparel, Iovera |
| Misonix INC | $47.29 | 2019 | |
| Acera Surgical, INC. | $43.64 | 2019-2020 | |
| Abbott Laboratories | $41.19 | 2021-2023 | Proclaim |
| Kci USA, INC. | $40.51 | 2020-2023 | Promogran Prisma, V.A.C.Instill, Activ.A.C. |
| Organogenesis INC. | $37.60 | 2021-2022 | |
| Polynovo North America LLC | $34.51 | 2025 | Novosorb Btm |
| Linvatec Corporation | $33.34 | 2022 | |
| Janssen Pharmaceuticals, INC | $32.44 | 2019-2022 | |
| Reprise Biomedical, INC. | $30.44 | 2025 | Miro3d |
| Access Pro Medical, LLC | $29.75 | 2023 | Matriderm |
| Arthrosurface Incorporated | $26.10 | 2019 | |
| Boston Scientific Corporation | $23.43 | 2024 | |
| Convatec INC. | $21.23 | 2024 | |
| Conetic Solutions, INC. | $20.56 | 2022 | |
| Averitas Pharma INC. | $18.56 | 2024 | Qutenza |
| Ani Pharmaceuticals, INC. | $17.62 | 2025 | Purified Cortrophin Gel |
| Paragon 28, INC. | $8.93 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.